Home/Filings/4/0001493152-21-026627
4//SEC Filing

Boehm Marcus 4

Accession 0001493152-21-026627

CIK 0001349929other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 4:30 PM ET

Size

5.6 KB

Accession

0001493152-21-026627

Insider Transaction Report

Form 4
Period: 2021-10-27
Boehm Marcus
Director
Transactions
  • Purchase

    Common Stock, $0.0001 par value

    2021-10-27$2.10/sh+5,000$10,500123,786 total(indirect: By Trust)
Footnotes (2)
  • [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person under the Boehm Family Trust, Marcus & Kimberley Boehm Trustees on May 24, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.07 to $2.17 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein

Documents

1 file

Issuer

Vyant Bio, Inc.

CIK 0001349929

Entity typeother

Related Parties

1
  • filerCIK 0001850698

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:30 PM ET
Size
5.6 KB